Company / Gross Margin
Boston Scientific Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
69.0%
FY2025
5-year range
68.6% / 71.0%
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
#24 of 96
Health Care
What the data says
Boston Scientific's gross margin of 69.0% is higher than 75% of companies in the Health Care sector (FY2025). Gross Margin remained relatively stable over the past 10 years, with values between 65.7% and 71.4%.
Based on SEC 10-K filings.
69.0% in FY2025 with a 5-year CAGR of -2.4%. Top quartile in the Health Care sector.
Remained stable around 69.0% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +0.2pp
- 5-Year Change
- -2.4pp
- 10-Year Change
- -
Sector benchmark
Top 25% in Health CareTop 25% of 96This company 69.0% Sector average 53.6%
▼
+28.8% above sector average
Key checks
Key Insights
- In FY2025, gross margin increased 0.6% year-over-year.
- Currently 15.4pp above the Health Care sector average.
- Peak gross margin was recorded in FY2020.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 69.0% | +0.6% |
| FY2024 | 68.6% | -1.3% |
| FY2023 | 69.5% | +1.0% |
| FY2022 | 68.8% | -3.1% |
| FY2021 | 71.0% | -0.5% |
| FY2020 | 71.4% | +0.5% |
| FY2019 | 71.0% | -0.5% |
| FY2018 | 71.4% | +0.0% |
| FY2017 | 71.3% | +8.6% |
| FY2016 | 65.7% | -0.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026